Hereditary nonpolyposis colorectal cancer (HNPCC)is the most common of the well-defined colorectal cancer syndromes , accounting for at least 2% of the total colorectal cancer burden and carrying a greater than 80% lifetime risk of cancer. Significant reduction in cancer morbidity and mortality can be accomplished by appropriate clinical cancer screening of HNPCC patients with mutations in mismatch repair (MMR) genes. Thus , it is desirable to identify individuals who are mutation-positive. In individuals with cancer , mutation detection can be accomplished relatively efficiently by germline mutation analysis of individuals whose cancers show microsatellite instability (MSI). This study was designed to assess the feasibility of screening colorectal adenoma patients for HNPCC in the same manner. Among 378 adenoma patients , six (1.6%) had at least one MSI adenoma. Five out of the six patients (83%) had a germline MMR gene mutation. We conclude that MSI analysis is a useful method of prescreening colorectal adenoma patients for HNPCC. (Am J Pathol 1999, 155:1849 -1853) Germline mutations in DNA mismatch repair genes (MLH1, MSH2, PMS1, PMS2, and MSH6) 1 underlie HNPCC. Deficient DNA mismatch repair results in reduced replication fidelity. Cells deficient for both alleles of a mismatch repair gene acquire a mutator phenotype, leading to accumulation of somatic mutations, which can be demonstrated by analyzing microsatellite sequences in the tumor DNA. These sequences display frequent somatic deletions and insertions, often referred to as microsatellite instability (MSI). HNPCC patients form adenomas at a slightly but not strikingly increased rate as compared with the general population 2 (Jä rvinen HJ, Aarnio M, Mustonen H, Aktan-Collan LA, Peltomäki P, de la Chapelle A, Mecklin J-P, submitted). Adenomas in HNPCC tend to be large and show a villous architecture and high-grade dysplasia. 3 It is possible that the mutator or MSI phenotype characteristic of HNPCC tumors drives the promotion of adenoma to carcinoma.MSI can be seen at an early stage in HNPCC tumors, but usually at later stages in sporadic colorectal tumorigenesis. 4 Adenomas from patients with HNPCC frequently show MSI as opposed to 0 to 3% of apparently sporadic colorectal adenomas. 5,6 The frequency of the MSI is 80 to 95% in HNPCC cancers 6 -8 and 10 to 15% in sporadic colorectal cancers. [7][8][9][10] The fact that a considerable proportion of sporadic colorectal cancers displays MSI makes microsatellite analysis a relatively unspecific marker for HNPCC when applied to malignant tumors.